Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01452 |
| Species: | Homo sapiens |
| Position : | chr13:40800476-40817024 |
| Year: | 2020 |
| Title: | Miswired Enhancer Logic Drives a Cancer of the Muscle Lineage. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | alveolar rhabdomyosarcoma |
| PMID: | 32416589 |
| MONDO: | MONDO:0009994 |
| Cell Source: | Rh4 |
| CVCL ID: | CVCL_5916 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay; TF binding assay; Chromatin interaction assay; Functional perturbation assay; Chromatin-state profiling |
| High Throughput Method: | ChIP-seq; ChIP-Rx; RNA-seq; 4C-seq; H3K27ac HiChIP; pooled CRISPR screen; HiChIP |
| Low Throughput Method: | Individual CRISPR-Cas9 enhancer perturbation; 3C PCR; RT-qPCR; Western blot; Sanger sequencing; ChIP |
| Target gene : | PAX3::FOXO1 |
| TF name : | MYCN |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| MYCN | Hs_Pathways_Affected_in_Adenoid_Cystic_Carcinoma_WP3651_89271 | wikipathways | 27 |